查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球霧化器市場：按類型、產品、應用、攜帶性、最終用戶分類：機會分析和產業預測（2023-2032）
市場調查報告書
商品編碼
1414703

全球霧化器市場：按類型、產品、應用、攜帶性、最終用戶分類：機會分析和產業預測（2023-2032）

Nebulizer Market By Type, By Product, By Application, By Portability, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 506 Pages | 商品交期: 2-3個工作天內

價格

預計2022年全球霧化器市場規模將達11億美元，2023年至2032年複合年成長率為7.8%，2032年將達23億美元。

霧化器市場-IMG1

霧化器市場的成長是由氣喘、慢性阻塞性肺病（COPD）、囊腫纖維化等呼吸系統疾病的日益普及所推動的。霧化器通常用於給藥和控制這些病症。例如，國家醫學圖書館報告稱，到 2022 年，慢性阻塞性肺病將影響世界十分之一的成年人口，並且是全球三大最常見的死亡原因之一。慢性阻塞性肺病也是全球健康差距的一個主要原因，並且在這種差距最極端的地區更為普遍。

此外，隨著世界人口持續老化，老年人更容易患呼吸道疾病，增加了對包括霧化器在內的呼吸照護設備的需求。此外，許多都市區的空氣污染水平不斷上升，導致呼吸道疾病的發生率上升。霧化器技術的進步提高了效率、易用性和攜帶性，使其對患者和醫療保健提供者都具有吸引力。

目錄

第1章簡介

第 2 章執行摘要

第3章市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
      • 呼吸道疾病盛行率上升
      • 老年人口增加
    • 抑制因素
      • 對居家醫療環境中霧化器的使用缺乏認知
    • 機會
      • 市場參與企業更採用關鍵策略

第4章霧化器市場：依類型

  • 概述
  • 噴射霧化器
  • 超音波霧化器
  • 網狀霧化器

第5章霧化器市場：依產品

  • 概述
  • 裝置
  • 配件

第6章霧化器市場：依應用分類

  • 概述
  • COPD（慢性阻塞性肺病）
  • 氣喘
  • 其他

第7章 霧化器市場：攜帶式性別

  • 概述
  • 桌面式
  • 攜帶式的

第 8 章 霧化器市場：依最終用戶分類

  • 概述
  • 醫院
  • 診所
  • 居家醫療環境

第9章霧化器市場：按地區

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 拉丁美洲/中東/非洲
    • 巴西
    • 沙烏地阿拉伯
    • 南非
    • 其他

第10章競爭形勢

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2022年）

第11章 公司簡介

  • OMRON Healthcare, Inc
  • Koninklijke Philips NV
  • PARI Respiratory Equipment Inc.
  • DeVilbiss Healthcare LLC.
  • GF Health Products, Inc.
  • Trudell Medical International Inc.
  • Allied Healthcare Products, Inc.
  • Teleflex Incorporated
  • Rossmax International Ltd
  • Vyaire Medical, Inc.
Product Code: A00308

According to a new report published by Allied Market Research, titled, "Nebulizer Market," The nebulizer market was valued at $1.1 billion in 2022, and is estimated to reach $2.3 billion by 2032, growing at a CAGR of 7.8% from 2023 to 2032.

Nebulizer Market - IMG1

The nebulizer market growth is driven by increase in prevalence of respiratory diseases such as

1) asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Nebulizers are commonly used to administer medication and manage these conditions. For instance, in 2022, according to National Library of Medicine, it was reported that, COPD affects 1 in 10 of the adult global population and is one of the three commonest causes of death worldwide. It is also a major cause of global inequalities in health and is more prevalent where such inequalities are more extreme.

Moreover, as the global population continues to age, there is a growing demand for respiratory care devices, including nebulizers, since older individuals are more susceptible to respiratory conditions. In addition, increase in levels of air pollution in many urban areas have led to a higher incidence of respiratory disorders and advances in nebulizer technology have improved their efficiency, ease of use, and portability, making them more appealing to both patients and healthcare providers.

In addition, a growing trend towards home healthcare and self-management of chronic illnesses has increased the use of nebulizers, as they can be used at home without the need for frequent hospital visits. Along with that Nebulizers are commonly used for children with respiratory issues, as they are effective and less intimidating than other delivery methods. The pediatric nebulizer market is a significant contributor to overall growth.

On the other hand, nebulizer devices, especially newer and more advanced models, can be expensive. This cost can be a barrier to access for some patients, particularly in regions with limited healthcare resources or for individuals with financial constraints. Thus, this factor is anticipated to restrain the growth of the market.

The nebulizer market is segmented into type, product, application, portability, end user, and region. Based on type the market is classified into jet nebulizer, ultrasonic nebulizer, and mesh nebulizer. Based on product, the market is segmented into equipment and accessories. Based on application the market is segmented into COPD, asthma and others. Based on potability, the market is bifurcated into tabletop and portable. Based on end user the market is divided into hospitals, clinics and homecare setting.

Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Major key players that operate in the global nebulizer market are OMRON Healthcare, Inc, Koninklijke Philips N.V., DeVilbiss Healthcare LLC., GF Health Products, Inc., Trudell Medical International Inc., Allied Healthcare Products, Inc., Teleflex Incorporated, Vyaire Medical, Inc., PARI Respiratory Equipment Inc., and Rossmax International Ltd. Key players operating in the market have adopted product approval, product launch, acquisition, and agreement as their key strategies to expand their nebulizer market share.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the nebulizer market analysis from 2022 to 2032 to identify the prevailing nebulizer market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the nebulizer market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global nebulizer market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Product Benchmarking / Product specification and applications
  • Upcoming/New Entrant by Regions
  • New Product Development/ Product Matrix of Key Players
  • Patient/epidemiology data at country, region, global level
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Type

  • Jet nebulizer
  • Ultrasonic nebulizer
  • Mesh nebulizer

By Product

  • Equipment
  • Accessories

By Application

  • COPD
  • Asthma
  • Others

By Portability

  • Tabletop
  • Portable

By End User

  • Hospital
  • Clinics
  • Homecare setting

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • DeVilbiss Healthcare LLC.
    • Trudell Medical International Inc.
    • Allied Healthcare Products, Inc.
    • Vyaire Medical, Inc.
    • PARI Respiratory Equipment Inc.
    • Rossmax International Ltd
    • OMRON Healthcare, Inc
    • GF Health Products, Inc.
    • Teleflex Incorporated
    • Koninklijke Philips N.V.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Low bargaining power of suppliers
    • 3.3.2. Low threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Low intensity of rivalry
    • 3.3.5. Low bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in prevalence of respiratory diseases.
      • 3.4.1.2. Increase in number of geriatric population.
    • 3.4.2. Restraints
      • 3.4.2.1. Lack of awareness regarding use of nebulizer at homecare setting
    • 3.4.3. Opportunities
      • 3.4.3.1. Rise in adoption of key strategies by market players

CHAPTER 4: NEBULIZER MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Jet nebulizer
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Ultrasonic nebulizer
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Mesh nebulizer
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: NEBULIZER MARKET, BY PRODUCT

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Equipment
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Accessories
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country

CHAPTER 6: NEBULIZER MARKET, BY APPLICATION

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. COPD
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Asthma
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: NEBULIZER MARKET, BY PORTABILITY

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Tabletop
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Portable
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country

CHAPTER 8: NEBULIZER MARKET, BY END USER

  • 8.1. Overview
    • 8.1.1. Market size and forecast
  • 8.2. Hospital
    • 8.2.1. Key market trends, growth factors and opportunities
    • 8.2.2. Market size and forecast, by region
    • 8.2.3. Market share analysis by country
  • 8.3. Clinics
    • 8.3.1. Key market trends, growth factors and opportunities
    • 8.3.2. Market size and forecast, by region
    • 8.3.3. Market share analysis by country
  • 8.4. Homecare setting
    • 8.4.1. Key market trends, growth factors and opportunities
    • 8.4.2. Market size and forecast, by region
    • 8.4.3. Market share analysis by country

CHAPTER 9: NEBULIZER MARKET, BY REGION

  • 9.1. Overview
    • 9.1.1. Market size and forecast By Region
  • 9.2. North America
    • 9.2.1. Key market trends, growth factors and opportunities
    • 9.2.2. Market size and forecast, by Type
    • 9.2.3. Market size and forecast, by Product
    • 9.2.4. Market size and forecast, by Application
    • 9.2.5. Market size and forecast, by Portability
    • 9.2.6. Market size and forecast, by End User
    • 9.2.7. Market size and forecast, by country
      • 9.2.7.1. U.S.
      • 9.2.7.1.1. Market size and forecast, by Type
      • 9.2.7.1.2. Market size and forecast, by Product
      • 9.2.7.1.3. Market size and forecast, by Application
      • 9.2.7.1.4. Market size and forecast, by Portability
      • 9.2.7.1.5. Market size and forecast, by End User
      • 9.2.7.2. Canada
      • 9.2.7.2.1. Market size and forecast, by Type
      • 9.2.7.2.2. Market size and forecast, by Product
      • 9.2.7.2.3. Market size and forecast, by Application
      • 9.2.7.2.4. Market size and forecast, by Portability
      • 9.2.7.2.5. Market size and forecast, by End User
      • 9.2.7.3. Mexico
      • 9.2.7.3.1. Market size and forecast, by Type
      • 9.2.7.3.2. Market size and forecast, by Product
      • 9.2.7.3.3. Market size and forecast, by Application
      • 9.2.7.3.4. Market size and forecast, by Portability
      • 9.2.7.3.5. Market size and forecast, by End User
  • 9.3. Europe
    • 9.3.1. Key market trends, growth factors and opportunities
    • 9.3.2. Market size and forecast, by Type
    • 9.3.3. Market size and forecast, by Product
    • 9.3.4. Market size and forecast, by Application
    • 9.3.5. Market size and forecast, by Portability
    • 9.3.6. Market size and forecast, by End User
    • 9.3.7. Market size and forecast, by country
      • 9.3.7.1. Germany
      • 9.3.7.1.1. Market size and forecast, by Type
      • 9.3.7.1.2. Market size and forecast, by Product
      • 9.3.7.1.3. Market size and forecast, by Application
      • 9.3.7.1.4. Market size and forecast, by Portability
      • 9.3.7.1.5. Market size and forecast, by End User
      • 9.3.7.2. France
      • 9.3.7.2.1. Market size and forecast, by Type
      • 9.3.7.2.2. Market size and forecast, by Product
      • 9.3.7.2.3. Market size and forecast, by Application
      • 9.3.7.2.4. Market size and forecast, by Portability
      • 9.3.7.2.5. Market size and forecast, by End User
      • 9.3.7.3. UK
      • 9.3.7.3.1. Market size and forecast, by Type
      • 9.3.7.3.2. Market size and forecast, by Product
      • 9.3.7.3.3. Market size and forecast, by Application
      • 9.3.7.3.4. Market size and forecast, by Portability
      • 9.3.7.3.5. Market size and forecast, by End User
      • 9.3.7.4. Italy
      • 9.3.7.4.1. Market size and forecast, by Type
      • 9.3.7.4.2. Market size and forecast, by Product
      • 9.3.7.4.3. Market size and forecast, by Application
      • 9.3.7.4.4. Market size and forecast, by Portability
      • 9.3.7.4.5. Market size and forecast, by End User
      • 9.3.7.5. Spain
      • 9.3.7.5.1. Market size and forecast, by Type
      • 9.3.7.5.2. Market size and forecast, by Product
      • 9.3.7.5.3. Market size and forecast, by Application
      • 9.3.7.5.4. Market size and forecast, by Portability
      • 9.3.7.5.5. Market size and forecast, by End User
      • 9.3.7.6. Rest of Europe
      • 9.3.7.6.1. Market size and forecast, by Type
      • 9.3.7.6.2. Market size and forecast, by Product
      • 9.3.7.6.3. Market size and forecast, by Application
      • 9.3.7.6.4. Market size and forecast, by Portability
      • 9.3.7.6.5. Market size and forecast, by End User
  • 9.4. Asia-Pacific
    • 9.4.1. Key market trends, growth factors and opportunities
    • 9.4.2. Market size and forecast, by Type
    • 9.4.3. Market size and forecast, by Product
    • 9.4.4. Market size and forecast, by Application
    • 9.4.5. Market size and forecast, by Portability
    • 9.4.6. Market size and forecast, by End User
    • 9.4.7. Market size and forecast, by country
      • 9.4.7.1. Japan
      • 9.4.7.1.1. Market size and forecast, by Type
      • 9.4.7.1.2. Market size and forecast, by Product
      • 9.4.7.1.3. Market size and forecast, by Application
      • 9.4.7.1.4. Market size and forecast, by Portability
      • 9.4.7.1.5. Market size and forecast, by End User
      • 9.4.7.2. China
      • 9.4.7.2.1. Market size and forecast, by Type
      • 9.4.7.2.2. Market size and forecast, by Product
      • 9.4.7.2.3. Market size and forecast, by Application
      • 9.4.7.2.4. Market size and forecast, by Portability
      • 9.4.7.2.5. Market size and forecast, by End User
      • 9.4.7.3. India
      • 9.4.7.3.1. Market size and forecast, by Type
      • 9.4.7.3.2. Market size and forecast, by Product
      • 9.4.7.3.3. Market size and forecast, by Application
      • 9.4.7.3.4. Market size and forecast, by Portability
      • 9.4.7.3.5. Market size and forecast, by End User
      • 9.4.7.4. Australia
      • 9.4.7.4.1. Market size and forecast, by Type
      • 9.4.7.4.2. Market size and forecast, by Product
      • 9.4.7.4.3. Market size and forecast, by Application
      • 9.4.7.4.4. Market size and forecast, by Portability
      • 9.4.7.4.5. Market size and forecast, by End User
      • 9.4.7.5. South Korea
      • 9.4.7.5.1. Market size and forecast, by Type
      • 9.4.7.5.2. Market size and forecast, by Product
      • 9.4.7.5.3. Market size and forecast, by Application
      • 9.4.7.5.4. Market size and forecast, by Portability
      • 9.4.7.5.5. Market size and forecast, by End User
      • 9.4.7.6. Rest of Asia-Pacific
      • 9.4.7.6.1. Market size and forecast, by Type
      • 9.4.7.6.2. Market size and forecast, by Product
      • 9.4.7.6.3. Market size and forecast, by Application
      • 9.4.7.6.4. Market size and forecast, by Portability
      • 9.4.7.6.5. Market size and forecast, by End User
  • 9.5. LAMEA
    • 9.5.1. Key market trends, growth factors and opportunities
    • 9.5.2. Market size and forecast, by Type
    • 9.5.3. Market size and forecast, by Product
    • 9.5.4. Market size and forecast, by Application
    • 9.5.5. Market size and forecast, by Portability
    • 9.5.6. Market size and forecast, by End User
    • 9.5.7. Market size and forecast, by country
      • 9.5.7.1. Brazil
      • 9.5.7.1.1. Market size and forecast, by Type
      • 9.5.7.1.2. Market size and forecast, by Product
      • 9.5.7.1.3. Market size and forecast, by Application
      • 9.5.7.1.4. Market size and forecast, by Portability
      • 9.5.7.1.5. Market size and forecast, by End User
      • 9.5.7.2. Saudi Arabia
      • 9.5.7.2.1. Market size and forecast, by Type
      • 9.5.7.2.2. Market size and forecast, by Product
      • 9.5.7.2.3. Market size and forecast, by Application
      • 9.5.7.2.4. Market size and forecast, by Portability
      • 9.5.7.2.5. Market size and forecast, by End User
      • 9.5.7.3. South Africa
      • 9.5.7.3.1. Market size and forecast, by Type
      • 9.5.7.3.2. Market size and forecast, by Product
      • 9.5.7.3.3. Market size and forecast, by Application
      • 9.5.7.3.4. Market size and forecast, by Portability
      • 9.5.7.3.5. Market size and forecast, by End User
      • 9.5.7.4. Rest of LAMEA
      • 9.5.7.4.1. Market size and forecast, by Type
      • 9.5.7.4.2. Market size and forecast, by Product
      • 9.5.7.4.3. Market size and forecast, by Application
      • 9.5.7.4.4. Market size and forecast, by Portability
      • 9.5.7.4.5. Market size and forecast, by End User

CHAPTER 10: COMPETITIVE LANDSCAPE

  • 10.1. Introduction
  • 10.2. Top winning strategies
  • 10.3. Product mapping of top 10 player
  • 10.4. Competitive dashboard
  • 10.5. Competitive heatmap
  • 10.6. Top player positioning, 2022

CHAPTER 11: COMPANY PROFILES

  • 11.1. OMRON Healthcare, Inc
    • 11.1.1. Company overview
    • 11.1.2. Key executives
    • 11.1.3. Company snapshot
    • 11.1.4. Operating business segments
    • 11.1.5. Product portfolio
    • 11.1.6. Business performance
  • 11.2. Koninklijke Philips N.V.
    • 11.2.1. Company overview
    • 11.2.2. Key executives
    • 11.2.3. Company snapshot
    • 11.2.4. Operating business segments
    • 11.2.5. Product portfolio
    • 11.2.6. Business performance
  • 11.3. PARI Respiratory Equipment Inc.
    • 11.3.1. Company overview
    • 11.3.2. Key executives
    • 11.3.3. Company snapshot
    • 11.3.4. Operating business segments
    • 11.3.5. Product portfolio
    • 11.3.6. Key strategic moves and developments
  • 11.4. DeVilbiss Healthcare LLC.
    • 11.4.1. Company overview
    • 11.4.2. Key executives
    • 11.4.3. Company snapshot
    • 11.4.4. Operating business segments
    • 11.4.5. Product portfolio
  • 11.5. GF Health Products, Inc.
    • 11.5.1. Company overview
    • 11.5.2. Key executives
    • 11.5.3. Company snapshot
    • 11.5.4. Operating business segments
    • 11.5.5. Product portfolio
  • 11.6. Trudell Medical International Inc.
    • 11.6.1. Company overview
    • 11.6.2. Key executives
    • 11.6.3. Company snapshot
    • 11.6.4. Operating business segments
    • 11.6.5. Product portfolio
  • 11.7. Allied Healthcare Products, Inc.
    • 11.7.1. Company overview
    • 11.7.2. Key executives
    • 11.7.3. Company snapshot
    • 11.7.4. Operating business segments
    • 11.7.5. Product portfolio
    • 11.7.6. Business performance
  • 11.8. Teleflex Incorporated
    • 11.8.1. Company overview
    • 11.8.2. Key executives
    • 11.8.3. Company snapshot
    • 11.8.4. Operating business segments
    • 11.8.5. Product portfolio
    • 11.8.6. Business performance
  • 11.9. Rossmax International Ltd
    • 11.9.1. Company overview
    • 11.9.2. Key executives
    • 11.9.3. Company snapshot
    • 11.9.4. Operating business segments
    • 11.9.5. Product portfolio
    • 11.9.6. Key strategic moves and developments
  • 11.10. Vyaire Medical, Inc.
    • 11.10.1. Company overview
    • 11.10.2. Key executives
    • 11.10.3. Company snapshot
    • 11.10.4. Operating business segments
    • 11.10.5. Product portfolio

LIST OF TABLES

  • TABLE 01. GLOBAL NEBULIZER MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 02. NEBULIZER MARKET FOR JET NEBULIZER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. NEBULIZER MARKET FOR ULTRASONIC NEBULIZER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. NEBULIZER MARKET FOR MESH NEBULIZER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. GLOBAL NEBULIZER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 06. NEBULIZER MARKET FOR EQUIPMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. NEBULIZER MARKET FOR ACCESSORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. GLOBAL NEBULIZER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 09. NEBULIZER MARKET FOR COPD, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. NEBULIZER MARKET FOR ASTHMA, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. NEBULIZER MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL NEBULIZER MARKET, BY PORTABILITY, 2022-2032 ($MILLION)
  • TABLE 13. NEBULIZER MARKET FOR TABLETOP, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. NEBULIZER MARKET FOR PORTABLE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL NEBULIZER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 16. NEBULIZER MARKET FOR HOSPITAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. NEBULIZER MARKET FOR CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. NEBULIZER MARKET FOR HOMECARE SETTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. NEBULIZER MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA NEBULIZER MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA NEBULIZER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 22. NORTH AMERICA NEBULIZER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA NEBULIZER MARKET, BY PORTABILITY, 2022-2032 ($MILLION)
  • TABLE 24. NORTH AMERICA NEBULIZER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 25. NORTH AMERICA NEBULIZER MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 26. U.S. NEBULIZER MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 27. U.S. NEBULIZER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 28. U.S. NEBULIZER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 29. U.S. NEBULIZER MARKET, BY PORTABILITY, 2022-2032 ($MILLION)
  • TABLE 30. U.S. NEBULIZER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 31. CANADA NEBULIZER MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 32. CANADA NEBULIZER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 33. CANADA NEBULIZER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 34. CANADA NEBULIZER MARKET, BY PORTABILITY, 2022-2032 ($MILLION)
  • TABLE 35. CANADA NEBULIZER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 36. MEXICO NEBULIZER MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 37. MEXICO NEBULIZER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 38. MEXICO NEBULIZER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 39. MEXICO NEBULIZER MARKET, BY PORTABILITY, 2022-2032 ($MILLION)
  • TABLE 40. MEXICO NEBULIZER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 41. EUROPE NEBULIZER MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 42. EUROPE NEBULIZER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 43. EUROPE NEBULIZER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 44. EUROPE NEBULIZER MARKET, BY PORTABILITY, 2022-2032 ($MILLION)
  • TABLE 45. EUROPE NEBULIZER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. EUROPE NEBULIZER MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 47. GERMANY NEBULIZER MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 48. GERMANY NEBULIZER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 49. GERMANY NEBULIZER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 50. GERMANY NEBULIZER MARKET, BY PORTABILITY, 2022-2032 ($MILLION)
  • TABLE 51. GERMANY NEBULIZER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. FRANCE NEBULIZER MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 53. FRANCE NEBULIZER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 54. FRANCE NEBULIZER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 55. FRANCE NEBULIZER MARKET, BY PORTABILITY, 2022-2032 ($MILLION)
  • TABLE 56. FRANCE NEBULIZER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 57. UK NEBULIZER MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 58. UK NEBULIZER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 59. UK NEBULIZER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 60. UK NEBULIZER MARKET, BY PORTABILITY, 2022-2032 ($MILLION)
  • TABLE 61. UK NEBULIZER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 62. ITALY NEBULIZER MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 63. ITALY NEBULIZER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 64. ITALY NEBULIZER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 65. ITALY NEBULIZER MARKET, BY PORTABILITY, 2022-2032 ($MILLION)
  • TABLE 66. ITALY NEBULIZER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. SPAIN NEBULIZER MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 68. SPAIN NEBULIZER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 69. SPAIN NEBULIZER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 70. SPAIN NEBULIZER MARKET, BY PORTABILITY, 2022-2032 ($MILLION)
  • TABLE 71. SPAIN NEBULIZER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 72. REST OF EUROPE NEBULIZER MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 73. REST OF EUROPE NEBULIZER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 74. REST OF EUROPE NEBULIZER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 75. REST OF EUROPE NEBULIZER MARKET, BY PORTABILITY, 2022-2032 ($MILLION)
  • TABLE 76. REST OF EUROPE NEBULIZER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 77. ASIA-PACIFIC NEBULIZER MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 78. ASIA-PACIFIC NEBULIZER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 79. ASIA-PACIFIC NEBULIZER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 80. ASIA-PACIFIC NEBULIZER MARKET, BY PORTABILITY, 2022-2032 ($MILLION)
  • TABLE 81. ASIA-PACIFIC NEBULIZER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 82. ASIA-PACIFIC NEBULIZER MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 83. JAPAN NEBULIZER MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 84. JAPAN NEBULIZER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 85. JAPAN NEBULIZER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 86. JAPAN NEBULIZER MARKET, BY PORTABILITY, 2022-2032 ($MILLION)
  • TABLE 87. JAPAN NEBULIZER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 88. CHINA NEBULIZER MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 89. CHINA NEBULIZER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 90. CHINA NEBULIZER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 91. CHINA NEBULIZER MARKET, BY PORTABILITY, 2022-2032 ($MILLION)
  • TABLE 92. CHINA NEBULIZER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 93. INDIA NEBULIZER MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 94. INDIA NEBULIZER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 95. INDIA NEBULIZER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 96. INDIA NEBULIZER MARKET, BY PORTABILITY, 2022-2032 ($MILLION)
  • TABLE 97. INDIA NEBULIZER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 98. AUSTRALIA NEBULIZER MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 99. AUSTRALIA NEBULIZER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 100. AUSTRALIA NEBULIZER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 101. AUSTRALIA NEBULIZER MARKET, BY PORTABILITY, 2022-2032 ($MILLION)
  • TABLE 102. AUSTRALIA NEBULIZER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 103. SOUTH KOREA NEBULIZER MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 104. SOUTH KOREA NEBULIZER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 105. SOUTH KOREA NEBULIZER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 106. SOUTH KOREA NEBULIZER MARKET, BY PORTABILITY, 2022-2032 ($MILLION)
  • TABLE 107. SOUTH KOREA NEBULIZER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 108. REST OF ASIA-PACIFIC NEBULIZER MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 109. REST OF ASIA-PACIFIC NEBULIZER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 110. REST OF ASIA-PACIFIC NEBULIZER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 111. REST OF ASIA-PACIFIC NEBULIZER MARKET, BY PORTABILITY, 2022-2032 ($MILLION)
  • TABLE 112. REST OF ASIA-PACIFIC NEBULIZER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 113. LAMEA NEBULIZER MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 114. LAMEA NEBULIZER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 115. LAMEA NEBULIZER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 116. LAMEA NEBULIZER MARKET, BY PORTABILITY, 2022-2032 ($MILLION)
  • TABLE 117. LAMEA NEBULIZER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 118. LAMEA NEBULIZER MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 119. BRAZIL NEBULIZER MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 120. BRAZIL NEBULIZER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 121. BRAZIL NEBULIZER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 122. BRAZIL NEBULIZER MARKET, BY PORTABILITY, 2022-2032 ($MILLION)
  • TABLE 123. BRAZIL NEBULIZER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 124. SAUDI ARABIA NEBULIZER MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 125. SAUDI ARABIA NEBULIZER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 126. SAUDI ARABIA NEBULIZER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 127. SAUDI ARABIA NEBULIZER MARKET, BY PORTABILITY, 2022-2032 ($MILLION)
  • TABLE 128. SAUDI ARABIA NEBULIZER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 129. SOUTH AFRICA NEBULIZER MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 130. SOUTH AFRICA NEBULIZER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 131. SOUTH AFRICA NEBULIZER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 132. SOUTH AFRICA NEBULIZER MARKET, BY PORTABILITY, 2022-2032 ($MILLION)
  • TABLE 133. SOUTH AFRICA NEBULIZER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 134. REST OF LAMEA NEBULIZER MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 135. REST OF LAMEA NEBULIZER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 136. REST OF LAMEA NEBULIZER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 137. REST OF LAMEA NEBULIZER MARKET, BY PORTABILITY, 2022-2032 ($MILLION)
  • TABLE 138. REST OF LAMEA NEBULIZER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 139. OMRON HEALTHCARE, INC: KEY EXECUTIVES
  • TABLE 140. OMRON HEALTHCARE, INC: COMPANY SNAPSHOT
  • TABLE 141. OMRON HEALTHCARE, INC: SERVICE SEGMENTS
  • TABLE 142. OMRON HEALTHCARE, INC: PRODUCT PORTFOLIO
  • TABLE 143. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
  • TABLE 144. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • TABLE 145. KONINKLIJKE PHILIPS N.V.: SERVICE SEGMENTS
  • TABLE 146. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
  • TABLE 147. PARI RESPIRATORY EQUIPMENT INC.: KEY EXECUTIVES
  • TABLE 148. PARI RESPIRATORY EQUIPMENT INC.: COMPANY SNAPSHOT
  • TABLE 149. PARI RESPIRATORY EQUIPMENT INC.: PRODUCT SEGMENTS
  • TABLE 150. PARI RESPIRATORY EQUIPMENT INC.: PRODUCT PORTFOLIO
  • TABLE 151. PARI RESPIRATORY EQUIPMENT INC.: KEY STRATERGIES
  • TABLE 152. DEVILBISS HEALTHCARE LLC.: KEY EXECUTIVES
  • TABLE 153. DEVILBISS HEALTHCARE LLC.: COMPANY SNAPSHOT
  • TABLE 154. DEVILBISS HEALTHCARE LLC.: PRODUCT SEGMENTS
  • TABLE 155. DEVILBISS HEALTHCARE LLC.: PRODUCT PORTFOLIO
  • TABLE 156. GF HEALTH PRODUCTS, INC.: KEY EXECUTIVES
  • TABLE 157. GF HEALTH PRODUCTS, INC.: COMPANY SNAPSHOT
  • TABLE 158. GF HEALTH PRODUCTS, INC.: PRODUCT SEGMENTS
  • TABLE 159. GF HEALTH PRODUCTS, INC.: PRODUCT PORTFOLIO
  • TABLE 160. TRUDELL MEDICAL INTERNATIONAL INC.: KEY EXECUTIVES
  • TABLE 161. TRUDELL MEDICAL INTERNATIONAL INC.: COMPANY SNAPSHOT
  • TABLE 162. TRUDELL MEDICAL INTERNATIONAL INC.: PRODUCT SEGMENTS
  • TABLE 163. TRUDELL MEDICAL INTERNATIONAL INC.: PRODUCT PORTFOLIO
  • TABLE 164. ALLIED HEALTHCARE PRODUCTS, INC.: KEY EXECUTIVES
  • TABLE 165. ALLIED HEALTHCARE PRODUCTS, INC.: COMPANY SNAPSHOT
  • TABLE 166. ALLIED HEALTHCARE PRODUCTS, INC.: PRODUCT SEGMENTS
  • TABLE 167. ALLIED HEALTHCARE PRODUCTS, INC.: PRODUCT PORTFOLIO
  • TABLE 168. TELEFLEX INCORPORATED: KEY EXECUTIVES
  • TABLE 169. TELEFLEX INCORPORATED: COMPANY SNAPSHOT
  • TABLE 170. TELEFLEX INCORPORATED: PRODUCT SEGMENTS
  • TABLE 171. TELEFLEX INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 172. ROSSMAX INTERNATIONAL LTD: KEY EXECUTIVES
  • TABLE 173. ROSSMAX INTERNATIONAL LTD: COMPANY SNAPSHOT
  • TABLE 174. ROSSMAX INTERNATIONAL LTD: PRODUCT SEGMENTS
  • TABLE 175. ROSSMAX INTERNATIONAL LTD: PRODUCT PORTFOLIO
  • TABLE 176. ROSSMAX INTERNATIONAL LTD: KEY STRATERGIES
  • TABLE 177. VYAIRE MEDICAL, INC.: KEY EXECUTIVES
  • TABLE 178. VYAIRE MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 179. VYAIRE MEDICAL, INC.: PRODUCT SEGMENTS
  • TABLE 180. VYAIRE MEDICAL, INC.: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. NEBULIZER MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF NEBULIZER MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN NEBULIZER MARKET (2022 TO 2032)
  • FIGURE 04. TOP INVESTMENT POCKETS IN NEBULIZER MARKET (2023-2032)
  • FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. LOW THREAT OF NEW ENTRANTS
  • FIGURE 07. LOW THREAT OF SUBSTITUTES
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. LOW BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL NEBULIZER MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. NEBULIZER MARKET, BY TYPE, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF NEBULIZER MARKET FOR JET NEBULIZER, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF NEBULIZER MARKET FOR ULTRASONIC NEBULIZER, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF NEBULIZER MARKET FOR MESH NEBULIZER, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. NEBULIZER MARKET, BY PRODUCT, 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF NEBULIZER MARKET FOR EQUIPMENT, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF NEBULIZER MARKET FOR ACCESSORIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. NEBULIZER MARKET, BY APPLICATION, 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF NEBULIZER MARKET FOR COPD, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF NEBULIZER MARKET FOR ASTHMA, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF NEBULIZER MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. NEBULIZER MARKET, BY PORTABILITY, 2022 AND 2032(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF NEBULIZER MARKET FOR TABLETOP, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF NEBULIZER MARKET FOR PORTABLE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 25. NEBULIZER MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 26. COMPARATIVE SHARE ANALYSIS OF NEBULIZER MARKET FOR HOSPITAL, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 27. COMPARATIVE SHARE ANALYSIS OF NEBULIZER MARKET FOR CLINICS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 28. COMPARATIVE SHARE ANALYSIS OF NEBULIZER MARKET FOR HOMECARE SETTING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 29. NEBULIZER MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 30. U.S. NEBULIZER MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. CANADA NEBULIZER MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. MEXICO NEBULIZER MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. GERMANY NEBULIZER MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. FRANCE NEBULIZER MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. UK NEBULIZER MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. ITALY NEBULIZER MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. SPAIN NEBULIZER MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. REST OF EUROPE NEBULIZER MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. JAPAN NEBULIZER MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. CHINA NEBULIZER MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. INDIA NEBULIZER MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. AUSTRALIA NEBULIZER MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. SOUTH KOREA NEBULIZER MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. REST OF ASIA-PACIFIC NEBULIZER MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. BRAZIL NEBULIZER MARKET, 2022-2032 ($MILLION)
  • FIGURE 46. SAUDI ARABIA NEBULIZER MARKET, 2022-2032 ($MILLION)
  • FIGURE 47. SOUTH AFRICA NEBULIZER MARKET, 2022-2032 ($MILLION)
  • FIGURE 48. REST OF LAMEA NEBULIZER MARKET, 2022-2032 ($MILLION)
  • FIGURE 49. TOP WINNING STRATEGIES, BY YEAR (2021-2022)
  • FIGURE 50. TOP WINNING STRATEGIES, BY DEVELOPMENT (2021-2022)
  • FIGURE 51. TOP WINNING STRATEGIES, BY COMPANY (2021-2022)
  • FIGURE 52. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 53. COMPETITIVE DASHBOARD
  • FIGURE 54. COMPETITIVE HEATMAP: NEBULIZER MARKET
  • FIGURE 55. TOP PLAYER POSITIONING, 2022
  • FIGURE 56. OMRON HEALTHCARE, INC: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 57. OMRON HEALTHCARE, INC: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 58. OMRON HEALTHCARE, INC: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 59. KONINKLIJKE PHILIPS N.V.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 60. KONINKLIJKE PHILIPS N.V.: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 61. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 62. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 63. ALLIED HEALTHCARE PRODUCTS, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 64. ALLIED HEALTHCARE PRODUCTS, INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 65. ALLIED HEALTHCARE PRODUCTS, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 66. TELEFLEX INCORPORATED: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 67. TELEFLEX INCORPORATED: REVENUE SHARE BY SEGMENT, 2022 (%)